Isracann Biosciences 

$0
4
+$0+900% Tuesday 13:30

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
-
Avg. Volume
-
Mkt Cap
1,629.69
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

27AprExpected
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2022
-0.06
-0.04
-0.02
-0
Expected EPS
N/A
Actual EPS
-0.0033

Financials

-Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
0Revenue
-7.42MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ISCNF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.
Show more...
CEO
Ajay Singh Kaila
Country
Canada
ISIN
CA46501D1087

Listings

0 Comments

Share your thoughts

FAQ

What is Isracann Biosciences stock price today?
The current price of ISCNF is $0 USD — it has increased by +900% in the past 24 hours. Watch Isracann Biosciences stock price performance more closely on the chart.
What is Isracann Biosciences stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Isracann Biosciences stocks are traded under the ticker ISCNF.
Is Isracann Biosciences stock price growing?
ISCNF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Isracann Biosciences has showed a +0% increase.
What is Isracann Biosciences market cap?
Today Isracann Biosciences has the market capitalization of 1,629.69
What were Isracann Biosciences earnings last quarter?
ISCNF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Isracann Biosciences revenue for the last year?
Isracann Biosciences revenue for the last year amounts to 0 USD.
What is Isracann Biosciences net income for the last year?
ISCNF net income for the last year is -7.42M USD.
In which sector is Isracann Biosciences located?
Isracann Biosciences operates in the Health & Wellness sector.
When did Isracann Biosciences complete a stock split?
The last stock split for Isracann Biosciences was on October 17, 2019 with a ratio of 1:3.
Where is Isracann Biosciences headquartered?
Isracann Biosciences is headquartered in Vancouver, Canada.